Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
University of Jena
ClinicalTrials.gov Identifier:
NCT00376233
First received: September 13, 2006
Last updated: October 11, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given